The management of complex wounds, such as burns, pressure ulcers, and chronic skin lesions, remains a major healthcare challenge owing to their prolonged healing process and high susceptibility to complications. These injuries frequently require extended hospitalization, increase the incidence of infections and surgical interventions, and compromise patients' functional capacity and quality of life. Furthermore, currently available wound dressings are often constrained by elevated manufacturing costs, inconsistent therapeutic performance, and reliance on imported biomaterials. To address these challenges, a bioactive wound dressing based on Stryphnodendron adstringens (barbatimão), a medicinal plant recognized by the Brazilian Pharmacopoeia for its wound-healing, anti-inflammatory, antioxidant, and antimicrobial properties, was developed. A standardized plant-derived active pharmaceutical ingredient was obtained through an optimized extraction process and successfully incorporated into a biocompatible polymeric matrix. The engineered membrane was designed to recreate an optimal wound microenvironment by maintaining moisture balance, permitting gas exchange, providing a protective barrier against external contaminants, and enabling sustained release of bioactive phytochemicals to prolong their therapeutic action. The developed biomaterials were thoroughly characterized using Attenuated Total Reflectance Fourier Transform Infrared Spectroscopy (ATR-FTIR), X-ray Diffraction (XRD), Thermogravimetric Analysis (TGA), Differential Thermal Analysis (DTA), Scanning Electron Microscopy (SEM), hydration studies, in vitro release assays, mechanical testing, and cytotoxicity evaluation. Overall, the membranes exhibited excellent physicochemical stability, favorable biocompatibility, and efficient incorporation and sustained release of natural bioactive compounds, demonstrating considerable promise for advanced biomedical and wound healing applications.